Takeda Pharmaceutical to redeem early remaining 2.45% notes due 2022

Chicago, April 19 – Takeda Pharmaceutical Co., Ltd. will redeem the remaining $200 million outstanding of 2.45% senior notes due 2022 (Cusips: 874060AC0, J8129EAE8) on May 17, according to a company notice.

The notes were originally issued on July 18, 2017.

The notes are being redeemed at the greater of par or the principal amount remaining plus the remaining payments of interest through the par call date plus Treasuries plus 10 basis points. Interest will also be paid.

The pharmaceutical company is based in Osaka, Japan.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.